The evolution of European HTA and access to innovative medicines
Kate Kolotourou, Petra Ermacora and Alexander Grosvenor comment on the evolution of health technology assessment in the European Union. This commentary, from the Journal of Comparative Effectiveness Research, is free to access exclusively for Evidence Base members.
Please sign in or register for FREE
Sign in to The Evidence Base
Did you know?
Your The Evidence Base™ account also gives you access to communities on regenerative medicine, real-world evidence and drug discovery. Find out more>>